Lamivudine
- Generic Name
- Lamivudine
- Brand Names
- Cimduo, Combivir, Delstrigo, Dovato, Epivir, Epivir Hbv, Epzicom, Kivexa, Symfi, Triumeq, Trizivir, Zeffix, Lamivudine Teva Pharma B.V., Lamivudine Teva
- Drug Type
- Small Molecule
- Chemical Formula
- C8H11N3O3S
- CAS Number
- 134678-17-4
- Unique Ingredient Identifier
- 2T8Q726O95
Overview
A reverse transcriptase inhibitor and zalcitabine analog in which a sulfur atom replaces the 3' carbon of the pentose ring. It is used to treat Human Immunodeficiency Virus Type 1 (HIV-1) and hepatitis B (HBV).
Background
A reverse transcriptase inhibitor and zalcitabine analog in which a sulfur atom replaces the 3' carbon of the pentose ring. It is used to treat Human Immunodeficiency Virus Type 1 (HIV-1) and hepatitis B (HBV).
Indication
For the treatment of HIV infection and chronic hepatitis B (HBV).
Associated Conditions
- Chronic Hepatitis B Infection
- Human Immunodeficiency Virus (HIV) Infections
- Human Immunodeficiency Virus Type 1 (HIV-1) Infection
Clinical Trials
FDA Approved Products
Lamivudine and Zidovudine
Manufacturer:H.J. Harkins Company, Inc.
Route:ORAL
Strength:150 mg in 1 1
Approved: 2012/06/25
NDC:76519-1005
Abacavir and Lamivudine
Manufacturer:Laurus Labs Limited
Route:ORAL
Strength:300 mg in 1 1
Approved: 2023/07/03
NDC:42385-962
Abacavir and lamivudine
Manufacturer:Zydus Lifesciences Limited
Route:ORAL
Strength:300 mg in 1 1
Approved: 2023/09/27
NDC:70771-1053
CIMDUO
Manufacturer:Mylan Specialty L.P.
Route:ORAL
Strength:300 mg in 1 1
Approved: 2018/03/22
NDC:49502-450
SYMFI LO
Manufacturer:Mylan Specialty L.P.
Route:ORAL
Strength:300 mg in 1 1
Approved: 2019/09/09
NDC:49502-425
Singapore Approved Products
No Singapore products found for this drug
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.
© Copyright 2025. All Rights Reserved by MedPath